AstraZeneca, CSPC Pharmaceuticals form AI-driven research partnership
LONDON: AstraZeneca has entered a strategic research collaboration with China-based CSPC Pharmaceuticals Group Limited to accelerate the discovery of novel oral therapies using artificial intelligence. The partnership will focus on identifying and developing pre-clinical candidates for chronic diseases, including a small-molecule oral…